Patent ID: 8257929

Claim:
A method of diagnosing Parkinson's Disease in a patient, comprising: detecting the level of expression of one or more genes selected from the group consisting of: the mitochondrial ribosome protein S6 (MRPS6) gene, the solute carrier family 5 gene (SLC5A3), the solute carrier family 38, member 2 gene (SLC38A2), the cAMP dependent protein kinase, the beta catalytic subunit gene (PRKACB), the cysteine and histidine-rich containing zinc binding protein 1 gene (CHORDC1), and the FUS interacting protein (serine/arginine-rich) 1 gene (FUSIP1), in a biological sample from said patient, wherein differential expression of said one or more genes in the sample as compared to control levels of expression of said one or more genes is indicative of Parkinson's Disease.